Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:20 PM
Ignite Modification Date:
2025-12-24 @ 10:20 PM
NCT ID:
NCT06887335
Eligibility Criteria:
Inclusion Criteria:
* Patients requiring a bronchoscopy-assisted procedure for diagnostic or therapeutic purposes
* Individuals who voluntarily consent to participate in the clinical study and sign a written informed consent form
Exclusion Criteria:
* Patients who have experienced acute myocardial infarction or acute stroke within the past six weeks
* Patients with contraindications to bronchoscopy (e.g., severe respiratory or cardiovascular comorbidities)
* Patients with a history of allergy to benzodiazepines, propofol, fentanyl, or flumazenil
* Patients with genetic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption
* Patients with a severe hypersensitivity reaction to dextran 40
* Patients with a history of acute angle-closure glaucoma
* Pregnant women
* Prisoners
* Patients with psychiatric disorders
* Patients classified as ASA Physical Status IV or V by the American Society of Anesthesiologists (ASA)
* Any other patients deemed unsuitable for the clinical study by the investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
90 Years
Study:
NCT06887335
Study Brief:
Protocol Section:
NCT06887335